Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. - Wikidata - wikimedia - TriplyDB

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

http://www.wikidata.org/entity/Q33288270

about

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation Influence of poly(D,L-lactic-co-glycolic acid) microsphere degradation on arteriolar remodeling in the mouse dorsal skinfold window chamber.Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression.Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents The effect of erythropoietin on normal and neoplastic cells.PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.Erythropoietic agents and the elderly.Using gene transfer to circumvent off-target effects.Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway.RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.Novel imaging provides new insights into mechanisms of oxygen transport in tumors.The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery.Erythropoietin: a hormone with multiple functions.Erythropoietin and Its Angiogenic Activity.Erythropoietin receptor contributes to melanoma cell survival in vivo.Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.Intravitreal recombinant human erythropoietin: a safety study in rabbits.Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.Epo is involved in angiogenesis in human glioma.

P2860

Q24240202-F727C148-36FF-498D-8E06-09C9CA4385AF Q24242864-66E938DB-D24A-4217-A7C4-7165F21428AF Q24306910-393EADB9-8114-4338-A865-8A9FD30824D8 Q30431749-7D385776-400A-4728-B7BA-FDE119AB0EFB Q33878270-58FE1DAB-84A2-4B35-8053-DB97EAA7A41E Q33920934-28E1F118-8436-473E-B5DC-7D9FE0F89558 Q34068226-A31DB373-EA16-4AAC-9C54-C80BA5A25AC1 Q34291437-2CC43E5C-917A-4E69-8B64-FB27F2148524 Q34429082-B1AB8652-D48E-4473-8AE5-4871AEB2571A Q34504572-48928D2D-0E43-4D3A-8C2C-89E1C7C59185 Q35164312-E47291C1-8310-4AAB-907D-B2F268343F93 Q35217404-5FB03390-A322-4A08-AE02-12713A40FB59 Q35432520-64766859-A116-486A-A500-83C9F0DD867A Q35544528-4842A873-E221-42CB-BD01-9073898D25E4 Q36645651-301CBA81-1904-48C1-BD5B-3F18ED061347 Q37046655-A68D47E4-4323-4D40-9671-EB24DD50B6E5 Q37098040-95D711CE-0050-4555-8CDB-2140E9AB5553 Q37115387-39EA301B-744F-491D-A5C3-A8C5FF9264A9 Q37151778-9CB3CB97-27D6-47B7-9740-D3CFCD9B0D05 Q37164573-D3952867-BDD6-45DD-A0A3-1A225B38B143 Q37230276-E00722A2-EC7B-48A9-8EF8-EB0A0A1BAD57 Q37253676-1074140D-429F-4C3F-88BD-1576AFDA30EB Q37515804-EF091715-2240-4B44-92E0-13E9F3B1C40C Q37639378-CB09FC59-70E7-42AE-9EE2-A9C359D47570 Q37862940-68A02A6E-D11D-4C83-869C-A23D7FF09AE6 Q39432541-1F1B6E3D-232E-49C0-B10A-FF9E649E587C Q39486076-79D974C1-7534-4D55-AAB0-2E1EF4A52068 Q39734169-E0B31DE0-B9DE-4B8A-A45B-047CD03AD02B Q39972736-F536F777-A579-4CC4-BEC7-03834A7ADF58 Q44034165-AFAA4187-09CE-48DA-B0BA-A041EF1AAE97 Q46082665-BB275439-0150-4840-AFC4-7CEFD7D2C2D5 Q46362748-4621963F-D18E-4A2A-9CA6-F5A6249D2899 Q47379071-ECC8665D-D18A-4F59-B5C9-54C3B240BEAB Q48135959-D6A9622D-8472-426E-9028-0D086FFF310E

P2860

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

http://www.wikidata.org/entity/Q33288270

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@ast

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@en

type

label

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@ast

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@en

prefLabel

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@ast

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@en

P1433

Q33288270-2DE3AFA6-4B9B-4005-88C5-A6510FD467D9

P1476

Q33288270-982C6EA2-36CA-4286-A9A6-87ED1F6BF032

P2093

Q33288270-2C224258-493C-455D-8C9C-35ECE24A695A

Q33288270-35F73CFD-3229-415E-8B73-FA5A3DD5CEBD

Q33288270-3A23AB6B-C224-410D-A9B8-031049DF7B37

Q33288270-3B9BDF71-8A21-4979-916D-1717133692C5

Q33288270-4BEC8D4B-A460-40C7-8FC9-4EB5F2CDABA2

Q33288270-B6374E56-B31E-4AC2-8877-9E35FF82D040

Q33288270-B6748F3F-FD01-48D1-B5D1-B2086A3FA449

Q33288270-D540BD1E-5064-4A6E-9040-F943FD657C19

Q33288270-FB397467-B132-4D05-AD36-448A7D67A52A

P2860

Q33288270-010D17A8-FAB2-4A09-8C83-EDE5386767B5

Q33288270-079D2338-5635-4C7E-AB8A-A2A99E114D84

Q33288270-1D273F64-0E41-41D5-9A0B-93636494FD09

Q33288270-25B88CC3-9DA3-4AF1-91A2-139A6EC50640

Q33288270-3260FD4E-DF89-4E48-A888-5E52F865190A

Q33288270-387DF5D2-CD8C-4483-A97E-6535F9C2AA10

Q33288270-3AEE7AD2-A6A2-4E48-BD4B-D51EDAC7CF6A

Q33288270-3B544525-7C45-426B-BAC4-812D25721E83

Q33288270-449D5E04-7CE6-441E-813A-2CF85D80852D

Q33288270-4680A048-0CEE-49F3-91BD-9BF5C0561313

P304

Q33288270-385D4001-A739-4145-9DC7-D45E3492FD12

P31

Q33288270-7431CA1E-CCE2-4C31-9B65-D991A245F0FE

P356

Q33288270-B209FCF7-38E6-477F-A346-807C99AAF8A1

P407

Q33288270-02218795-D995-4036-B20A-7F6D8B52E263

P433

Q33288270-9AB56A0F-E7A2-4E45-9976-224EBA258EF9

P478

Q33288270-CC82A95E-6E17-4D15-AAA1-6395E9AFD9D3

P577

Q33288270-3E5B1B19-9629-40DD-AC87-496AD6F1FE19

P5875

Q33288270-DEE5D03A-2E9A-46F6-84B5-5140654B2DE7

P698

Q33288270-45478BCC-20B0-4AA9-B86D-B052BC4B1EEE

P921

Q33288270-D390070A-C685-4975-ADD1-062F337BCB90

P932

Q33288270-86877667-353F-4B7D-A251-CF55676C6660

P356

JOURNAL.PONE.0000549

P1433

P1476

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

@en

P2093

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Matthew E Hardee

http://www.w3.org/2001/XMLSchema#string

Murat O Arcasoy

http://www.w3.org/2001/XMLSchema#string

Ping Fu

http://www.w3.org/2001/XMLSchema#string

Xiaohong Jiang

http://www.w3.org/2001/XMLSchema#string

Yiting Cao

http://www.w3.org/2001/XMLSchema#string

Yulin Zhao

http://www.w3.org/2001/XMLSchema#string

Zahid N Rabbani

http://www.w3.org/2001/XMLSchema#string

Zeljko Vujaskovic

http://www.w3.org/2001/XMLSchema#string

P2860

A novel role for erythropoietin during fibrin-induced wound-healing response

Erythropoietin and VEGF exhibit equal angiogenic potential.

Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration.

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.

A novel protective effect of erythropoietin in the infarcted heart

Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor gr

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Erythropoietin biology in cancer.

P304

e549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0000549

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6256959

http://www.w3.org/2001/XMLSchema#string

P698

17579721

http://www.w3.org/2001/XMLSchema#string

P921

P932

1891087

http://www.w3.org/2001/XMLSchema#string